The acute hemodynamic effects of intravenous verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography
The acute hemodynamic effects of an i.v. bolus of verapamil, 0.1 mg/kg or 0.06-0.075 mg/kg, were examined by serial radionuclide studies in 46 patients with coronary artery disease. In 20 patients with ejection fractions (EFs) greater than 35% (group 1A), verapamil, 0.1 mg/kg given over 1-11/2 minutes, had a biphasic effect: first, a transient decrease in EF accompanied by increased left ventricular (LV) volumes and cardiac output equivalents; then, an overshoot of EF to values above control, accompanied by a decrease in peripheral vascular resistance and a drastic decrease in LV volumes, while cardiac output equivalent remained slightly elevated. In eight patients with EFs less than 35% (group 1B), only the first effect on EF was noted. In 10 patients with EFs greater than 35% (group 2), verapamil, 0.06-0.075 mg/kg, exerted qualitatively similar but milder effects on hemodynamic function. Finally, verapamil, 0.1 mg/kg given more slowly, over 2-21/2 minutes, produced no significant changes in EF or LV volumes in another eight patients (group 3). The acute effects of verapamil are thus both time-related and dose-dependent. They are also related to the baseline functional reserve of the left ventricle. This study documents that verapamil exerts a depressant effect on LV function. However, the transient nature of this depression and the quick recovery to normal or above-normal values indicate that verapamil, in the doses used in this study, is safe to use intravenously in patients with coronary artery disease.
- Research Organization:
- Department of Cardiology, Meir General Hospital, Kfar-Saba, Israel
- OSTI ID:
- 6430722
- Journal Information:
- Circulation; (United States), Vol. 67:1
- Country of Publication:
- United States
- Language:
- English
Similar Records
The value of exercise radionuclide ventriculography in risk stratification in patients with known or suspected coronary artery disease
Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function
Related Subjects
59 BASIC BIOLOGICAL SCIENCES
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
VASCULAR DISEASES
THERAPY
VASODILATORS
BIOLOGICAL EFFECTS
BLOOD CIRCULATION
CORONARIES
DIAGNOSTIC USES
DYNAMIC FUNCTION STUDIES
HEART
PATIENTS
RADIOPHARMACEUTICALS
ARTERIES
BLOOD VESSELS
BODY
CARDIOVASCULAR AGENTS
CARDIOVASCULAR SYSTEM
DISEASES
DRUGS
LABELLED COMPOUNDS
ORGANS
USES
550601* - Medicine- Unsealed Radionuclides in Diagnostics
550901 - Pathology- Tracer Techniques
560306 - Chemicals Metabolism & Toxicology- Man- (-1987)